Boston Scientific Corp has unveiled the Precision Montage MRI Spinal Cord Stimulator (SCS) system, which recently garnered FDA approval. The Precision system, which offers customized relief to patients with chronic pain via MultiWave Technology, enables the performance of full-body MRI in a 1.5T environment when certain conditions are met. Such technology is a major boon to patients, company officials say, since they no longer have to compromise pain relief for MRI access.
The new SCS system also expands the suite of Boston Scientific products that leverage the Illumina 3D algorithm, an anatomy-driven computer model designed for point-and-click pain targeting to support physicians in treating chronic pain. In addition to the new Precision Montage MRI SCS system, the portfolio includes the Precision Spectra system, which is designed to provide broad coverage for pain with 32 contacts, and the Precision Novi system, a high-capacity nonrechargeable device.
Salim Hayek, MD, PhD, program director for anesthesiology pain medicine at the Cleveland-based University Hospital Case Medical Center, extolls the benefits of Boston Scientific’s technology, saying the Illumina 3D portfolio allows him to tailor treatment to each patient. “With the approval of the Precision Montage MRI SCS system, more of my patients can benefit from this powerful technology since they can now have access to future MRI scan needs,” he adds.
Boston Scientific’s senior vice president Maulik Nanavaty concurs, calling the Precision Montage MRI SCS system a key addition to the Illumina 3D portfolio. “[It] offers patients more choices to manage and personalize their therapy—an important advancement [that] underscores our commitment to meet the individual needs of chronic pain patients.”
For more information about this equipment, visit Boston Scientific.
